Continuous central venous and pulmonary artery oxygen saturation monitoring in cardiac surgery after cardiopulmonary bypass

2007 ◽  
Vol 24 (Supplement 39) ◽  
pp. 41
Author(s):  
A. Ducart ◽  
M. Dejonckheere ◽  
M. Koch ◽  
L. Perrin ◽  
D. Schmartz
2010 ◽  
Vol 27 (3) ◽  
pp. 295-299 ◽  
Author(s):  
Pierre-Yves Lequeux ◽  
Yves Bouckaert ◽  
Hicham Sekkat ◽  
Philippe Van der Linden ◽  
Constantin Stefanidis ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Kota Saito ◽  
Sho Ohno ◽  
Makishi Maeda ◽  
Naoyuki Hirata ◽  
Michiaki Yamakage

Abstract Background Remimazolam has less cardiovascular depressant effects than propofol in non-cardiac surgical patients. However, the efficacy and safety of remimazolam in cardiac surgery with cardiopulmonary bypass (CPB) have not been reported. We present a case of successful anesthetic management using remimazolam in cardiac surgery with CPB. Case presentation A 76-year-old female was scheduled for mitral valve repair, tricuspid annuloplasty, maze procedure, and left atrial appendage closure. We used remimazolam in induction (6.0 mg/kg/h) and maintenance (0.6–1.0 mg/kg/h) of general anesthesia, and the bispectral index value was maintained in the range of 36 to 48 including the period of CPB. Hemodynamics, mixed venous oxygen saturation, and bilateral regional cerebral oxygen saturation were maintained within acceptable ranges. There was no intraoperative awareness/recall or serious complications associated with remimazolam throughout the perioperative period. Conclusions Remimazolam can be used the same as other existing anesthetics in cardiac surgery with CPB.


2020 ◽  
Vol 24 (2) ◽  
pp. 33-39
Author(s):  
marwa mahrous ◽  
Khaled Hassan ◽  
Abdelrahman Abdelrahman ◽  
Abd El Hady Helmy

Sign in / Sign up

Export Citation Format

Share Document